News

Following on from our recent announcement that we would be working with the Foundation for Angelman Syndrome Therapeutics (FAST) to find new treatments for Angelman Syndrome, we interviewed Dr Allyson Berent, Chief Scientific Officer at FAST, to learn more about the organisation and the ways in which AI is being used to speed up drug discovery … Continued

In this webinar we explore developing in vitro models for your rare disease research – from both a patient group and industry perspective. Over the course of the 60-minute session our speakers discuss the following topics: 
What makes a good in vitro model The pros and cons of in vitro model system types The use … Continued